Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 14/20 | 0.38 |
| ▸ | ADM2 | Q7Z4H4 | 4/20 | 0.38 |
| ▸ | RAMP1 | O60894 | 6/20 | 0.37 |
| ▸ | CALCB | P10092 | 3/20 | 0.37 |
| ▸ | CALCA | P06881 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30637920 | 0.89 | CALCRL (0.38) | CALCRLADM2RAMP1CALCBCALCA | |
| SCHEMBL30637905 | 0.87 | CALCRL (0.40) | CALCRLADM2RAMP1CALCA | |
| SCHEMBL31511800 | 0.86 | CALCRL (0.38) | CALCRLADM2RAMP1CALCBCALCA | |
| SCHEMBL30637915 | 0.81 | KCNH2 (0.38) | CALCRLADM2RAMP1CALCBCALCA | |
| SCHEMBL30637910 | 0.78 | CALCRL (0.39) | CALCRLADM2RAMP1CALCBCALCA | |
| SCHEMBL31511804 | 0.77 | CALCA (0.36) | CALCRLADM2RAMP1CALCBCALCA | |
| SCHEMBL31084968 | 0.75 | CALCRL (0.58) | CALCRLRAMP1 | |
| SCHEMBL4571727 | 0.75 | CALCRL (0.58) | CALCRLRAMP1 | |
| SCHEMBL20664259 | 0.75 | CALCRL (0.58) | CALCRLRAMP1 | |
| SCHEMBL31126005 | 0.75 | CALCRL (0.58) | CALCRLRAMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353860-A1 | PIPERIDINE CARBOXAMIDE AZAINDANE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | BRISE PHARMACEUTICALS CO., LTD. (CN) | 2025-11-20 | — | — | US | disclosed |
| EP-4516793-A1 | PIPERIDINE CARBOXAMIDE AZAINDANE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | Brise Pharmaceuticals Co., Ltd. (CN) | 2025-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353860-A1 | PIPERIDINE CARBOXAMIDE AZAINDANE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | CALCR, CNR2, CALCRL | CALCRL 3/4885ADM2 133/4885RAMP1 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.